|
CRNX | Crinetics Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.42 |
| Leverage | 11.91% |
| Market Cap | $ 2.4B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -463.5m |
| Margin | -5812.28% |
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.